Featured Research

from universities, journals, and other organizations

Enzyme That Protects Against Intestinal Bacterial Toxin Identified

Date:
February 19, 2008
Source:
Massachusetts General Hospital
Summary:
How the lining of the small intestine, through which nutrients are absorbed, also prevents intestinal bacteria from entering the bloodstream has been a mystery. Now researchers have found that an intestinal enzyme may be able to block the action of the bacterial toxin involved in the overwhelming infection known as sepsis. The findings may also explain why patients recovering from serious injury are less likely to develop infections if they receive gastrointestinal nutrition.

A persistent mystery in human medicine is how the lining of the small intestine, through which nutrients are absorbed, also prevents intestinal bacteria and their toxins from entering the bloodstream and causing serious infections. A team of researchers from Massachusetts General Hospital (MGH) has found that a specific intestinal enzyme may be able to block the action of the bacterial toxin involved in the overwhelming infection known as sepsis. The findings, which will appear in the Proceedings of the National Academy of Sciences, may also explain why patients recovering from serious injury are less likely to develop infections if they receive gastrointestinal nutrition.

"It's been known for many years that people who don't eat, particularly those who are ill or recovering from injury, are more susceptible to infections derived from the gut," says Richard Hodin, MD, of the MGH Department of Surgery, the study's senior author. "We know that eating -- even small amounts of nutrients delivered through a feeding tube -- can help prevent infections, and it may be that the production of this enzyme is the key to that protection. Everyone that takes care of critically ill patients knows the importance of 'feeding the gut,' but how that feeding works to prevent infection has been a mystery."

Intestinal alkaline phosphatase (IAP) is produced by cells lining the small intestine, and several previous studies suggested that IAP might block the action of lipopolysaccharide (LPS), a molecule on the surface of many pathogenic bacteria that is responsible for their toxic effects. In order to investigate the normal function of IAP in the intestine -- something that has not been understood -- the MGH research team conducted a number of experiments with intestinal cell lines and confirmed that those cells' expression of IAP could block the toxic effects of LPS.

A comparison of normal mice with mice in whom the IAP gene had been knocked out showed that the animals lacking IAP lost their protection against intestinal bacteria. The investigators also showed that IAP expression and the ability to detoxify LPS were decreased markedly when the animals did not eat for two days, a defect that was reversed when feeding resumed.

"Our results show that IAP produced in the intestinal lining and secreted into the gut can detoxify LPS and prevent bacteria from becoming harmful," Hodin says. "In addition to explaining how feeding can protect ICU patients from infection, these findings may have significant implications for a variety of conditions, including inflammatory bowel disease. Studies are ongoing to determine the role that IAP may play in those disorders." Hodin is a professor of Surgery at Harvard Medical School.

The work was performed in Hodin's lab, which is supported by grants from the National Institutes of Health. First author Ross Goldberg, MD, is now at St. Vincent's Hospital, New York. Additional co-authors are William Austen, Jr, MD, Xiaobo Zhang, Gitonga Munene, Golam Mostafa, Shaluk Biswas, Michael McCormack, Kyle Eberlin, John Nguyen, MD, and Hamit Tatlidede of MGH Surgery; H. Shaw Warren, MD, MGH Pediatrics; and Sonoko Narisawa, PhD, and Jose Millan, PhD, Burnham Institute for Medical Research, La Jolla, Calif.


Story Source:

The above story is based on materials provided by Massachusetts General Hospital. Note: Materials may be edited for content and length.


Cite This Page:

Massachusetts General Hospital. "Enzyme That Protects Against Intestinal Bacterial Toxin Identified." ScienceDaily. ScienceDaily, 19 February 2008. <www.sciencedaily.com/releases/2008/02/080218172437.htm>.
Massachusetts General Hospital. (2008, February 19). Enzyme That Protects Against Intestinal Bacterial Toxin Identified. ScienceDaily. Retrieved August 23, 2014 from www.sciencedaily.com/releases/2008/02/080218172437.htm
Massachusetts General Hospital. "Enzyme That Protects Against Intestinal Bacterial Toxin Identified." ScienceDaily. www.sciencedaily.com/releases/2008/02/080218172437.htm (accessed August 23, 2014).

Share This




More Health & Medicine News

Saturday, August 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Newsy (Aug. 21, 2014) An experimental drug used to treat Marburg virus in rhesus monkeys could give new insight into a similar treatment for Ebola. Video provided by Newsy
Powered by NewsLook.com
Two US Ebola Patients Leave Hospital Free of the Disease

Two US Ebola Patients Leave Hospital Free of the Disease

AFP (Aug. 21, 2014) Two American missionaries who were sickened with Ebola while working in Liberia and were treated with an experimental drug are doing better and have left the hospital, doctors say on August 21, 2014. Duration: 01:05 Video provided by AFP
Powered by NewsLook.com
Cadavers, a Teen, and a Medical School Dream

Cadavers, a Teen, and a Medical School Dream

AP (Aug. 21, 2014) Contains graphic content. He's only 17. But Johntrell Bowles has wanted to be a doctor from a young age, despite the odds against him. He was recently the youngest participant in a cadaver program at the Indiana University NW medical school. (Aug. 21) Video provided by AP
Powered by NewsLook.com
American Ebola Patients Released: What Cured Them?

American Ebola Patients Released: What Cured Them?

Newsy (Aug. 21, 2014) It's unclear whether the American Ebola patients' recoveries can be attributed to an experimental drug or early detection and good medical care. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins